Global Pyrogen Testing Market Size study & Forecast, by Product (Kits and Reagents, Services, Instruments), Test Type (LAL Tests, Rabbit Pyrogen Test, Monocyte Activation Test, and Other Test Types), End User (Pharmaceutical and Biotechnology Companies, M

Global Pyrogen Testing Market Size study & Forecast, by Product (Kits and Reagents, Services, Instruments), Test Type (LAL Tests, Rabbit Pyrogen Test, Monocyte Activation Test, and Other Test Types), End User (Pharmaceutical and Biotechnology Companies, Medical Device Companies, and Other End Users), and Regional Analysis, 2023-2030

Global Pyrogen Testing Market is valued approximately at USD 1187.5 million in 2022 and is anticipated to grow with a growth rate of more than 9.8% over the forecast period 2023-2030. Pyrogen testing often performed to identify pyrogen contamination in pharmaceutical dosage forms and medical equipment. Following delivery, pyrogen-contaminated injections can result in a variety of life-threatening issues, including shock, fever, inflammation, and body aches. The market growth is driven by key factors such as rising R&D Expenditure in Life Science, rapid Growth in Pharmaceutical and Biotechnology Industries, and increased chronic disease burden.

According to Statista, A total of USD 285 billion were invested in life sciences agreements globally in 2020. Additionally, the pharmaceutical sector spent a total of USD 238 billion on research & development globally in 2021. In contrast, R&D costs came to USD 207 billion in 2020. Also, the World Health Organization (WHO) states that chronic diseases are the primary reason for global mortality. In 2019, ischemic heart disease alone accounted for approximately 8.89 million deaths. Collectively, cardiovascular diseases result in around 17.9 million fatalities each year. Moreover, the rise in the incidences of infectious diseases and research and development enhanced global market opportunities in Pyrogen Testing Market. However, stringent Government Regulations stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Pyrogen Testing Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is leading the global market share owing to increasing number of pharmaceutical and biopharmaceutical companies. However, APAC is expected to be the fastest growing region due to the availability of less stringent government regulations for drug development in the region.


Major market player included in this report are:
Microcoat Biotechnologie GmbH
Lonza Group
Merck Kgaa
Thermo Fisher Scientific Inc.
Fujifilm Holdings Corporation (FUJIFILM Wako Pure Chemical Corporation)
WUXI Pharmatech (Cayman) Inc.
Eurofins Scientific
Microcoat Biotechnologie GmbH
Sotera Health (Nelson Laboratories LLC)
Sanquin Health Solution


Recent Developments in the Market:
 In July 2020, Lonza Sales AG and Sanquin Reagents BV established an alliance for the sale of a variety of specialised reagents for the monocyte activation test (MAT)-based pyrogen testing of parenteral medicines and medical devices.
 In July 2020, Lonza and Sanquin Reagents formed a strategic partnership for the sale of a variety of specialized reagents for the monocyte activation test-based pyrogen testing of parenteral medicines and medical devices. This collaboration has contributed to the growth of Lonza's wide range of endotoxin testing solutions. As a result, all of these characteristics are discovered to stimulate market expansion generally.

Global Pyrogen Testing Market Report Scope:
 Historical Data – 2020 - 2021
 Base Year for Estimation – 2022
 Forecast period - 2023-2030
 Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
 Segments Covered - Product, Test Type, End User Region
 Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Kits and Reagents
Services
Instruments

By Test Type:
LAL Tests
Rabbit Pyrogen Test
Monocyte Activation Test
Other Test Types
By End User:
Pharmaceutical and Biotechnology Companies
Medical Device Companies
Other End Users

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Companies Mentioned
Microcoat Biotechnologie GmbH
Lonza Group
Merck Kgaa
Thermo Fisher Scientific Inc.
Fujifilm Holdings Corporation (FUJIFILM Wako Pure Chemical Corporation)
WUXI Pharmatech (Cayman) Inc.
Eurofins Scientific
Microcoat Biotechnologie GmbH
Sotera Health (Nelson Laboratories LLC)
Sanquin Health Solution

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.